Summary

Samenvatting endocrinologie

1 purchase

Course
Metabolism and hormones 2

Institution
Universiteit Antwerpen (UA)

Uitgebreide samenvatting endocrinologie: zeer gedetailleerd. Lesnota's van verschillende jaren gecombineerd incl mijn eigen lesnota's gebasseerd op videolessen (zeer gedetailleerd). Overzichtelijk en gestructureerd per topic. puntjes, Geen volzinnen. Ideaal om te studeren voor examen.

[Show more]

Preview 4 out of 106 pages

View example

Uploaded on January 12, 2024
Number of pages 106
Written in 2020/2021
Type Summary

endocrinologie
diabetes mellitus
diabetes
hormonen
schildklier
thyroid
hyperthyroidie
hypothyroidie
acromegalie
prolactinoom
lesnotas
metabolisme
farmacologie
samenvatting

Institution
Universiteit Antwerpen (UA)
Education
Geneeskunde
Course
Metabolism and hormones 2

vanhaudtlaura

Member since 1 year 9 documents sold

$8.10

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

ENDOCRINOLOGIE

Uantwerpen, Prof. Dr. De Block

1

,Inhoudsopgave
1 HYPOFYSE ADENOOM ............................................................................................................. 5
2 HYPOPITUARISME ................................................................................................................... 7
2.1 ETIOLOGIE .................................................................................................................................8
2.2 KLINIEK .....................................................................................................................................9
2.3 GROEIHORMOON DEFICIËNTIE.....................................................................................................10
3 ACROMEGALIE ...................................................................................................................... 12
3.1 ETIOLOGIE ...............................................................................................................................12
3.2 KLINIEK ...................................................................................................................................12
3.3 BEHANDELING..........................................................................................................................13
4 PROLACTINOOM ................................................................................................................... 15
4.1 ETIOLOGIE ...............................................................................................................................15
4.2 KLINIEK ...................................................................................................................................15
4.3 BEHANDELING..........................................................................................................................16
5 NEUROHYPOFYSE .................................................................................................................. 17
5.1 DIABETES INSIPIDUS ..................................................................................................................17
5.2 SIADH ...................................................................................................................................18
6 SYNDROOM VAN CUSHING ................................................................................................... 20
6.1 KLINIEK ...................................................................................................................................21
6.2 DIAGNOSE ...............................................................................................................................22
6.3 BEHANDELING..........................................................................................................................23
7 ZIEKTE VAN ADDISON............................................................................................................ 25
7.1 ETIOLOGIE ...............................................................................................................................25
7.2 KLINIEK ...................................................................................................................................25
7.3 BEHANDELING..........................................................................................................................27
8 PRIMAIRE ALDOSTEROSIME + ZELDZAME BIJNIERZIEKTE ....................................................... 28
8.1 PRIMAIR ALDOSTERONISME ........................................................................................................28
8.2 FEOCHROMOCYTOOM ...............................................................................................................30
8.3 SURRENALE HYPERANDROGENEMIE..............................................................................................31
9 HYPERTHYROÏDIE .................................................................................................................. 33
9.1 ZIEKTE VAN GRAVES-BASEDOW ..................................................................................................33
9.2 TOXISCH SCHILDKLIER ................................................................................................................35
9.3 T HYROÏDITIS............................................................................................................................36
10 HYPOTHRYOÏDIE.................................................................................................................... 38
10.1 HASHIMOTO: AUTOIMMUNE THYROÏDITIS .....................................................................................39
11 SCHILDKLIER GOITER EN NODULE .......................................................................................... 41

2

, 11.1 EUTHYROÏDISCHE GOITER ...........................................................................................................41
11.2 KLINIEK ...................................................................................................................................42
11.3 SOLITAIRE NODULE ...................................................................................................................43
12 SCHILDKLIER CARCINOOM ..................................................................................................... 45
13 HYPERCALCIËMIE .................................................................................................................. 48
13.1 CALCIUM HOMEOSTASE .............................................................................................................48
13.2 OORZAKEN ..............................................................................................................................48
13.3 KLINIEK ...................................................................................................................................50
13.4 BEHANDELING..........................................................................................................................51
14 MULTIPLE ENDOCRIENE NEOPLASIE (MEN) SYNDROOM ........................................................ 53
15 HYPOCALCIËMIE .................................................................................................................... 54
15.1 ETIOLOGIE ...............................................................................................................................54
15.2 KLINIEK ...................................................................................................................................55
16 HIRSUTISME .......................................................................................................................... 57
16.1 ETIOLOGIE ...............................................................................................................................58
16.2 POLYCYSTISCH OVARIEEL SYNDROOM ...........................................................................................58
16.3 ANDERE OORZAKEN ..................................................................................................................59
16.4 KLINIEK ...................................................................................................................................60
17 GYNECOMASTIE .................................................................................................................... 62
17.1 PATHOFYSIOLOGIE ....................................................................................................................62
17.2 OORZAKEN .......................................................................... FOUT! BLADWIJZER NIET GEDEFINIEERD.
17.3 DIAGNOSE ...............................................................................................................................64
17.4 BEHANDELING..........................................................................................................................64
18 DIABETES .............................................................................................................................. 66
18.1 DIABETES MELLITUS TYPE 1 ........................................................................................................67
18.2 DIABETES MELLITUS TYPE 2 ........................................................................................................68
18.3 HYPERGLYCEMIE .......................................................................................................................69
18.3.1 Acute hyperglycemische keto-acidotische coma .........................................................69
18.3.2 Hyperosmolair non-ketotische hyperglycemische coma .............................................71
18.3.3 Medicatie gerelateerde acidose ..................................................................................71
18.4 HYPOGLYCEMIE ........................................................................................................................72
19 DIABETES CHRONISCHE COMPLICATIES ................................................................................. 75
19.1 HET BELANG VAN METABOLE CONTROLE .......................................................................................75
19.2 RETINOPATHIE .........................................................................................................................76
19.3 NEFROPATHIE ..........................................................................................................................76
19.4 NEUROPATHIE..........................................................................................................................77
19.4.1 Senso-somatische neuropathie ...................................................................................78
19.4.2 Autonome neuropathie ...............................................................................................79
19.5 MACROVASCULAIRE COMPLICATIES..............................................................................................80
19.6 DE DIABETEISCHE VOET ..............................................................................................................81

3

, 19.7 ANDERE COMPLICATIES..............................................................................................................82
20 DIABETES: BEHANDELING ...................................................................................................... 83
20.1 DIABTES MELLITUS TYPE 1 ..........................................................................................................83
20.2 DIABETES MELLITUS TYPE 2: ORALE ANTIDIABETICA + GLP-1 (INJECTIE)..............................................84
20.3 RICHTLIJNEN ............................................................................................................................89
21 HYPOGLYCEMIE BIJ NIET DIABETEN ....................................................................................... 93
21.1 ETIOLOGIE ...............................................................................................................................93
21.1.1 Ziekte pt of medicatie ..................................................................................................93
21.1.2 Gezonde pt ..................................................................................................................94
21.2 DIAGNOSE ...............................................................................................................................95
21.3 DUMPING SYNDROOM...............................................................................................................96
22 HYPERLIPIDEMIE ................................................................................................................... 98
22.1 PATHOFYSIOLOGIE ....................................................................................................................98
22.2 CLASSIFICATIE ..........................................................................................................................98
22.3 BEHANDELING........................................................................................................................100
23 OBESITAS ............................................................................................................................ 103
23.1 PATHOFYSIOLOGIE ..................................................................................................................103
23.2 OORZAKEN ............................................................................................................................103
23.3 COMPLICATIES .......................................................................................................................105
23.4 BEHANDELING........................................................................................................................105

4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller vanhaudtlaura. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.10. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

68175 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling

Summary

Samenvatting endocrinologie

Document information

Subjects

Written for

Seller

Reviews received

Content preview